Bionomics Limited (BNOX)
Bionomics Statistics
Share Statistics
Bionomics has 19.58M shares outstanding. The number of shares has increased by 83.07% in one year.
| 19.58M |
| 83.07% |
| 0% |
| 8.91% |
| n/a |
| 12,069 |
| 1.37% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bionomics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.02.
| 3.45 |
| 3.45 |
| 0.02 |
| -0.03 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,936,520,750 |
| 8 |
| 0 |
| n/a |
Taxes
| -87.32M |
| 850.12% |
Stock Price Statistics
The stock price has increased by -97.8% in the last 52 weeks. The beta is -0.07, so Bionomics's price volatility has been lower than the market average.
| -0.07 |
| -97.8% |
| 3.57 |
| 7.11 |
| 47.66 |
| 881,890 |
Balance Sheet
The company has 12.61M in cash and 272.74K in debt, giving a net cash position of 12.34M.
| 12.61M |
| 272.74K |
| 12.34M |
| -177.98M |
| 18.17M |
| 2.26M |
Cash Flow
In the last 12 months, operating cash flow was -14.68M and capital expenditures -4.44, giving a free cash flow of -14.68M.
| -14.68M |
| -4.44 |
| -14.68M |
| -1.47 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
BNOX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for BNOX is $8, which is 3100% higher than the current price. The consensus rating is "Buy".
| $8 |
| 3100% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Dec 24, 2024. It was a backward split with a ratio of 1:12.
| Dec 24, 2024 |
| backward |
| 1:12 |
Scores
| -16.24 |
| 5 |